Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8 Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Differential regulation of cytokine production is mediated by IL-17 in obese children with obstructive sleep apnoea Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016
Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnea patients Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Production of TNF-α, MMPs, and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
Endothelial and systemic inflammation in obstructive sleep apnea syndrome: Impact of CPAP therapy on CRP plasma levels Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Serum midkine levels in patients with obstructive sleep apnea Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Source: Eur Respir J , 49 (4) 1601731; DOI: 10.1183/13993003.01731-2016 Year: 2017
Alteration of inflammatory mediators in patients with obstructive sleep apnea Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Interrelationships between oxidative stress and MMP-9 in subjects with severe obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Effect of CPAP therapy on cardiovascular risk in severe obstructive sleep apnea:the MMP:TIMP balance Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
The severity of sleep-disordered breathing is independently associated with increased peripheral leukocytes and neutrophils in overweight children and adolescents Source: Annual Congress 2007 - Sleep apnoea in childhood Year: 2007
Local airway inflammation in obstructive sleep apnoea: the role of leptin Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006
Effects of obstructive sleep apnoea on systemic inflammation and adipose tissue expression of CD40, MKK4 and JNK Source: International Congress 2014 – Inflammation and obesity: implications for OSA Year: 2014
Serum sCD163 as a biomarker of adipose tissue inflammation in obstructive sleep apnoea patients: limits and perspectives Source: Eur Respir J, 50 (2) 1701182; 10.1183/13993003.01182-2017 Year: 2017
Serum sCD163 as a biomarker of adipose tissue inflammation in obstructive sleep apnoea patients: limits and perspectives Source: Eur Respir J, 50 (2) 1701038; 10.1183/13993003.01038-2017 Year: 2017